BioCatalystWatch
OSTXWorkspace / OSTX / OverviewCompany library
Price
Market cap
Next catalystMid-Q4 2026 UK initiation, following Phase 2b drug-product requalificationOST-HER2 — planned UK confirmatory Phase 3 · Trial initiationCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

OST-tADC

PreINDP1P2P3FilingApproved

HER2

PreINDP1P2FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

HER2

PreINDP1P2FilingApproved
Upcoming / outlook

OST-tADC

PreINDP1P2P3FilingApproved

Other pipelines

OST-503

KRAS G12 mutant antigens

OST-503

KRAS G12 mutant antigens

PreINDP1P2P3FilingApproved
OST-503

KRAS G12 mutant antigens

PreINDP1P2P3FilingApproved
OST-504

PSA × Cancer-testis antigens × Treatment-resistance mutations

PreINDP1P2P3FilingApproved
OST-504

PSA × Cancer-testis antigens × Treatment-resistance mutations

PreINDP1P2P3FilingApproved
OST-AXAL

PreINDP1P2P3FilingApproved
OST-tADC-A

Folate receptor alpha (FRα)

PreINDP1P2P3FilingApproved
OST-tADC-FRA-H

Folate receptor alpha (FRα)

PreINDP1P2P3FilingApproved
OST31-164 (OST-HER2)

HER2

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

OSTX SEC archive